Search Orphan Drug Designations and Approvals
-
Generic Name: | rapamycin |
---|---|
Date Designated: | 03/20/2007 |
Orphan Designation: | Treatment of tuberous sclerosis complex |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
OncoImmune, Inc. 333 Parkland Plaza Suite 1000 Ann Arbor, Michigan 48103 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-